Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 7.4.2021Octapharma AB (OCP-S-1)3428BNuwiq 250 IU prášok a rozpúšťadlo na injekčný roztok (plv iol 1x250 IU+1x2,5 ml solv.+adapter inj.liek. (liek.inj.skl.+striek.inj.skl.napl.))7.4.2021O
 7.4.2021STALLERGENES (SLG-1)53626ALYOSTAL PRICK (sol tdp 1x3 ml (100 IR/ml, 100 IC/ml, 1000 IC/ml) (liek.skl.))19.5.2020O
 6.4.2021Takeda GmbH (TKD-3)6559ACONTROLOC i.v. (plv ino 5x40 mg (liek.skl.-nem.bal.))6.4.2021R
 6.4.2021PRO.MED.CS Praha a.s. (PMP-1)59596FAMOSAN 40 mg (tbl flm 50x40 mg (blis.PVC/Al))10.5.2021R
 6.4.2021Takeda Manufacturing Austria AG (TKM-5)97248KIOVIG 100 mg/ml infúzny intravenózny roztok (sol inf 1x100 ml/10 g (liek.inj.skl.))6.4.2021R
 6.4.2021sanofi-aventis groupe (SOI-1)58809CLEXANE FORTE 12000 IU (120 mg)/0,8 ml (sol inj 10x0,8 ml/120 mg (striek.inj.napl.skl.) s bezp.systémom (E))1.4.2021O
 6.4.2021AS KALCEKS (AKA)7795CAtracurium Kalceks 10 mg/ml injekčný/infúzny roztok (sol ijf 5x5 ml/50 mg (amp.skl.))6.4.2021O
 6.4.2021Novartis Europharm Limited (NEH-IE)3977AExelon 13,3 mg/24 h transdermálna náplasť (emp tdm 30x13,3 mg/24 hodín (vre.pap.PET/Al/PAN))20.6.2021Z
 6.4.2021Novartis Europharm Limited (NEH-IE)3977AExelon 13,3 mg/24 h transdermálna náplasť (emp tdm 30x13,3 mg/24 hodín (vre.pap.PET/Al/PAN))20.6.2021R
 1.4.2021Sanofi-Aventis groupe (SOI)2707BZenon 10 mg/40 mg (tbl flm 90x10 mg/40 mg (blis.OPA/Al/PVC/Al-povolenie uvádzať na trh končí dňa 31.05.2022))31.5.2021Z
 1.4.2021sanofi-aventis groupe (SOI-1)25611FRISIUM (tbl 20x10 mg (blis.Al/PVC))29.3.2021O
 1.4.2021Sandoz GmbH (SAN-A)35715Azithromycin Sandoz 500 mg filmom obalené tablety (tbl flm 3x500 mg (blis.PVC/PVDC/Al))6.4.2021R
 1.4.2021Sandoz GmbH (SAN-A)4594BPregabalin Sandoz 75 mg tvrdé kapsuly (cps dur 56x1x75 mg (blis.PVC/PVDC/Al-perf.))6.4.2021R
 1.4.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)38291Fentanyl Sandoz 25 µg/h matrix transdermálna náplasť (emp tdm 5x25 µg/1 h)1.4.2021O
 1.4.2021Sandoz Pharmaceuticals d.d. (SAN-SLO-1)54211Letrozol Sandoz 2,5 mg filmom obalené tablety (tbl flm 100x2,5 mg (blis.PVC/Al))6.4.2021R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)